http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05262736-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate | 1992-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1993-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H05262736-A |
| titleOfInvention | Phenoxyacetic acid derivative |
| abstract | (57) [Summary] [Structure] Formula 1 shown below (where X is hydrogen, Represents a halogen atom, lower alkyl, trifluoromethyl, alkoxy, hydroxy or cyano group, R 1 represents a carboxyl group, an alkoxycarbonyl group (wherein the alkoxy group has 1 to 4 carbon atoms, and is linear or branched) A chain) or a tetrazole group, A represents oxygen or the following formula 2 or formula 3, and m and n represent an integer of 0 or 1) or a physiologically acceptable phenoxyacetic acid derivative thereof. Possible salt. [Chemical 1] [Chemical 2] [Chemical 3] [Effect] Since the compound of the present invention has a thromboxane A 2 antagonism and a leukotriene antagonism, it is an effective preventive agent against allergic diseases such as thrombosis and asthma, which are diseases involving thromboxane A 2 and leukotrienes. Can be used as |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009090976-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9721691-A1 |
| priorityDate | 1992-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 95.